Rigel Pharmaceuticals | RIGL - Trade Creditors

Stock Price
26.27
Daily Change
-1.82 -6.48%
Monthly
-3.98%
Yearly
43.87%
Q2 Forecast
28.79

Rigel Pharmaceuticals reported $3.85M in Trade Creditors for its fiscal quarter ending in September of 2025.





Trade Creditors Change Date
Agenus USD 82.99M 2.3M Dec/2025
Amgen USD 19.52B 1.37B Mar/2026
Anika Therapeutics USD 6.34M 298K Mar/2026
Arrowhead Research USD 32.94M 15.26M Dec/2025
AstraZeneca USD 22.51B 2.78B Mar/2026
BioMarin Pharmaceutical USD 793.15M 34.12M Mar/2026
Bristol-Myers Squibb USD 4.23B 659M Mar/2026
Celldex Therapeutics USD 1.18M 3.09M Dec/2025
Daiichi Sankyo JPY 568.5B 16.84B Dec/2025
Eli Lilly USD 5.03B 350M Mar/2026
Halozyme Therapeutics USD 20.9M 5.54M Dec/2025
Heron Therapeutics USD 8.99M 3.02M Dec/2025
Intrexon USD 4.85M 3.12M Jun/2024
Ionis Pharmaceuticals USD 26.03M 2.05M Mar/2026
Karyopharm Therapeutics USD 4M 1.39M Dec/2025
Ligand Pharmaceuticals USD 3.24M 24.52M Dec/2025
MacroGenics USD 4.79M 1.15M Dec/2025
Neurocrine Biosciences USD 691.3M 145.8M Mar/2026
Pfizer USD 4.51B 734M Mar/2026
Regeneron Pharmaceuticals USD 1.03B 4.81B Mar/2026
Rigel Pharmaceuticals USD 3.85M 3.44M Sep/2025
Sangamo BioSciences USD 10.74M 7.46M Jun/2025
Ultragenyx Pharmaceutical USD 42M 11M Mar/2026
Veracyte USD 6.91M 2.32M Mar/2026